The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Avian Influenza Vaccines Market Research Report 2024

Global Avian Influenza Vaccines Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1408761

No of Pages : 114

Ask Your Query

Synopsis

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.Avian Influenza Vaccines is a kind of vaccine used to prevent infection caused by Avian Influenza bacteria.

The global Avian Influenza Vaccines market was valued at US$ 949 million in 2023 and is anticipated to reach US$ 1386.6 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.

Global Avian Influenza Vaccines key players include Merial, QYH Biotech, DHN, HVRI, etc. Global top four manufacturers hold a share over 80%.

China is the largest market, with a share about 45%, followed by Asia (Ex.China), and North America, both have a share about 40 percent.

In terms of product, Type H5 is the largest segment, with a share over 70%. And in terms of application, the largest application is Chicken, followed by Duck and Goose, etc.

This report aims to provide a comprehensive presentation of the global market for Avian Influenza Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Avian Influenza Vaccines.

Report Scope

The Avian Influenza Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Avian Influenza Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Avian Influenza Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Merial
  • QYH Biotech
  • DHN
  • HVRI
  • CEVA
  • Elanco (Lohmann )
  • Yebio
  • Zoetis
  • FATRO
  • Kyoto Biken
  • CAVAC
  • Ringpu Biology
  • Vaksindo
  • ChengDu Tecbond
  • Sindh Poultry Vaccine Centre
  • Merck Animal Health
  • Medion
  • Avimex Animal Health
  • JOVAC
  • Bio-Labs

Segment by Type

  • H5+H7 Avian Influenza Vaccines
  • H9 Avian Influenza Vaccines
  • Segment by Application
  • Chicken Avian Influenza Vaccines
  • Duck & Goose Avian Influenza Vaccines
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Avian Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Avian Influenza Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Avian Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Avian Influenza Vaccines
1.2 Avian Influenza Vaccines Segment by Type
1.2.1 Global Avian Influenza Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Avian Influenza Vaccines Segment by Application
1.3.1 Global Avian Influenza Vaccines Market Value by Application: (2024-2030)
1.3.2 Chicken Avian Influenza Vaccines
1.3.3 Duck & Goose Avian Influenza Vaccines
1.3.4 Other
1.4 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Avian Influenza Vaccines Revenue 2019-2030
1.4.2 Global Avian Influenza Vaccines Sales 2019-2030
1.4.3 Global Avian Influenza Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Avian Influenza Vaccines Market Competition by Manufacturers
2.1 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Avian Influenza Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Avian Influenza Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Avian Influenza Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Avian Influenza Vaccines, Product Type & Application
2.7 Avian Influenza Vaccines Market Competitive Situation and Trends
2.7.1 Avian Influenza Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Avian Influenza Vaccines Players Market Share by Revenue
2.7.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avian Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Avian Influenza Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Avian Influenza Vaccines Global Avian Influenza Vaccines Sales by Region: 2019-2030
3.2.1 Global Avian Influenza Vaccines Sales by Region: 2019-2024
3.2.2 Global Avian Influenza Vaccines Sales by Region: 2025-2030
3.3 Global Avian Influenza Vaccines Global Avian Influenza Vaccines Revenue by Region: 2019-2030
3.3.1 Global Avian Influenza Vaccines Revenue by Region: 2019-2024
3.3.2 Global Avian Influenza Vaccines Revenue by Region: 2025-2030
3.4 North America Avian Influenza Vaccines Market Facts & Figures by Country
3.4.1 North America Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Avian Influenza Vaccines Sales by Country (2019-2030)
3.4.3 North America Avian Influenza Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Avian Influenza Vaccines Market Facts & Figures by Country
3.5.1 Europe Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Avian Influenza Vaccines Sales by Country (2019-2030)
3.5.3 Europe Avian Influenza Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Avian Influenza Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Avian Influenza Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
3.7.1 Latin America Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Avian Influenza Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Avian Influenza Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Avian Influenza Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Avian Influenza Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Avian Influenza Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Avian Influenza Vaccines Sales by Type (2019-2030)
4.1.1 Global Avian Influenza Vaccines Sales by Type (2019-2024)
4.1.2 Global Avian Influenza Vaccines Sales by Type (2025-2030)
4.1.3 Global Avian Influenza Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Avian Influenza Vaccines Revenue by Type (2019-2030)
4.2.1 Global Avian Influenza Vaccines Revenue by Type (2019-2024)
4.2.2 Global Avian Influenza Vaccines Revenue by Type (2025-2030)
4.2.3 Global Avian Influenza Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Avian Influenza Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Avian Influenza Vaccines Sales by Application (2019-2030)
5.1.1 Global Avian Influenza Vaccines Sales by Application (2019-2024)
5.1.2 Global Avian Influenza Vaccines Sales by Application (2025-2030)
5.1.3 Global Avian Influenza Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Avian Influenza Vaccines Revenue by Application (2019-2030)
5.2.1 Global Avian Influenza Vaccines Revenue by Application (2019-2024)
5.2.2 Global Avian Influenza Vaccines Revenue by Application (2025-2030)
5.2.3 Global Avian Influenza Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Avian Influenza Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merial Avian Influenza Vaccines Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 QYH Biotech
6.2.1 QYH Biotech Corporation Information
6.2.2 QYH Biotech Description and Business Overview
6.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
6.2.5 QYH Biotech Recent Developments/Updates
6.3 DHN
6.3.1 DHN Corporation Information
6.3.2 DHN Description and Business Overview
6.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 DHN Avian Influenza Vaccines Product Portfolio
6.3.5 DHN Recent Developments/Updates
6.4 HVRI
6.4.1 HVRI Corporation Information
6.4.2 HVRI Description and Business Overview
6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HVRI Avian Influenza Vaccines Product Portfolio
6.4.5 HVRI Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 CEVA Avian Influenza Vaccines Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 Elanco (Lohmann )
6.6.1 Elanco (Lohmann ) Corporation Information
6.6.2 Elanco (Lohmann ) Description and Business Overview
6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
6.6.5 Elanco (Lohmann ) Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Yebio Avian Influenza Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 FATRO
6.9.1 FATRO Corporation Information
6.9.2 FATRO Description and Business Overview
6.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 FATRO Avian Influenza Vaccines Product Portfolio
6.9.5 FATRO Recent Developments/Updates
6.10 Kyoto Biken
6.10.1 Kyoto Biken Corporation Information
6.10.2 Kyoto Biken Description and Business Overview
6.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
6.10.5 Kyoto Biken Recent Developments/Updates
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Avian Influenza Vaccines Description and Business Overview
6.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
6.11.5 CAVAC Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Avian Influenza Vaccines Description and Business Overview
6.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Vaksindo
6.13.1 Vaksindo Corporation Information
6.13.2 Vaksindo Avian Influenza Vaccines Description and Business Overview
6.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
6.13.5 Vaksindo Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Avian Influenza Vaccines Description and Business Overview
6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 Sindh Poultry Vaccine Centre
6.15.1 Sindh Poultry Vaccine Centre Corporation Information
6.15.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Description and Business Overview
6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
6.15.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
6.16 Merck Animal Health
6.16.1 Merck Animal Health Corporation Information
6.16.2 Merck Animal Health Avian Influenza Vaccines Description and Business Overview
6.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
6.16.5 Merck Animal Health Recent Developments/Updates
6.17 Medion
6.17.1 Medion Corporation Information
6.17.2 Medion Avian Influenza Vaccines Description and Business Overview
6.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Medion Avian Influenza Vaccines Product Portfolio
6.17.5 Medion Recent Developments/Updates
6.18 Avimex Animal Health
6.18.1 Avimex Animal Health Corporation Information
6.18.2 Avimex Animal Health Avian Influenza Vaccines Description and Business Overview
6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
6.18.5 Avimex Animal Health Recent Developments/Updates
6.19 JOVAC
6.19.1 JOVAC Corporation Information
6.19.2 JOVAC Avian Influenza Vaccines Description and Business Overview
6.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
6.19.5 JOVAC Recent Developments/Updates
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Avian Influenza Vaccines Description and Business Overview
6.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
6.20.5 Bio-Labs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Avian Influenza Vaccines Industry Chain Analysis
7.2 Avian Influenza Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Avian Influenza Vaccines Production Mode & Process
7.4 Avian Influenza Vaccines Sales and Marketing
7.4.1 Avian Influenza Vaccines Sales Channels
7.4.2 Avian Influenza Vaccines Distributors
7.5 Avian Influenza Vaccines Customers
8 Avian Influenza Vaccines Market Dynamics
8.1 Avian Influenza Vaccines Industry Trends
8.2 Avian Influenza Vaccines Market Drivers
8.3 Avian Influenza Vaccines Market Challenges
8.4 Avian Influenza Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock